Session: S27-Nodular Thyroid Disease: Understanding and Assessing Risk
Supported by Genzyme, a Sanofi company
Room 103 (Moscone Center)
Thyroid nodules are common; most are benign. The standard evaluation involves fine needle aspiration, though over 30% may return adequate but cytologically indeterminate. In such cases, surgery is often recommended, though over 50% of cases prove benign thus submitting patients to unnecessary risk, cost, and morbidity. Recently, robust molecular markers have been developed and validated for use on such patients. The have led to a paradigm shift in clinical care. This clinical arena, and an up to date analysis of the state of the art, will be discussed.
See more of: Symposia